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Abstract
Objective: The aim of this study was to examine rates of psychotropic medication use over time among a national probability
sample of youths involved with child welfare=child protective services (CW=CPS) in the National Survey of Child and
Adolescent Well-Being (NSCAW).
Methods: Growth mixture modeling was used to classify 2,521 youths into groups based on individual medication use
trajectories. Determinants associated with groupings were examined using logistic regression.
Results:Overall, 22% of youths used medications over 3 years. Three groups were identified: (1) Low medication use (85%,
n¼ 2,057), where medication was used rarely or never; (2) increasing medication use, where medication was commonly
started after investigation (4%, n¼ 148); and (3) high medication use, where medication use was endorsed over multiple study
waves (12%, n¼ 316). On multivariate modeling, physical abuse predicted membership in the increasing-use group (refer-
ence group, low use); Caucasian (versus African American) and need predicted membership in the high-use group (reference
group, low use). Male gender was associated with membership in both the increasing-use and high-use groups (reference
group, low use). Age and abuse type (physical abuse, neglect) demonstrated complex relationships with group membership.
Conclusions: Psychotropic medication use trajectories for children in child welfare vary and are best understood when
disaggregated into distinct subpopulations.
Introduction
Youths involved with the child welfare=child protectiveservices system (CW=CPS) represent a uniquely vulnerable
subpopulation of U.S. youths. Their numbers are staggering: In
2006, caregivers of approximately 6.0 million youths were reported
for abuse or neglect and roughly 510,000 youths were living in out-
of-home care on any given day (U.S. Department of Health and
Human Services, Administration for Children, Youth and Families
2008a; U.S. Department of Health and Human Services, Admin-
istration for Children, Youth and Families 2008b). These youths
share histories characterized by abuse, neglect, domestic violence,
poverty, and in utero and environmental drug exposure. Research
has confirmed the negative impact of these risk factors; high rates of
behavioral problems have consistently been documented among
youths investigated by CW=CPS, whether or not they are removed
from their home and placed into out-of-home care or remain in the
care of their parents (Simms and Halfon 1994; Pilowsky 1995;
Clausen et al. 1998; Landsverk et al. 2002; Burns et al. 2004).
A relatively large body of research now exists describing out-
patient mental health services use by youths investigated by
CW=CPS. Most of the recent data come from the National Study of
Child and Adolescent Well-Being (NSCAW), a longitudinal, na-
tional probability cohort of over 5,500 youths undergoing investi-
gation for alleged abuse and=or neglect (Dowd et al. 2004). These
data indicate that outpatient mental health services use among
youths in CW=CPS reflect the presence of clinically significant
behavioral problems as well as moderating factors, such as age,
race=ethnicity, and maltreatment history (Burns et al. 2004).
In contrast to the numbers of studies describing service use, there
is a relative dearth of data regarding psychotropic medication use.
The few regional studies available show rates of medication use
ranging from 13% to 37%, (Zima et al. 1999a; Zima et al. 1999b;
Breland-Noble et al. 2004; McMillen et al. 2004; Raghavan et al.
2005; Ferguson et al. 2006; Zito et al. 2008) compared with ap-
proximately 4% in youths in the general population (Olfson et al.
2002). One national study, using data fromNSCAW, estimated that
approximately 14% of youths were using psychotropic medications
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approximately 12 months following investigation. Age, gender,
Caucasian race=ethnicity, history of physical abuse, public insur-
ance, and borderline=clinical cutoff scores on the Child Behavior
Checklist were associated with higher proportions of medication
use (Raghavan et al. 2005). All of these studies to date have been
cross sectional in nature and have not examined rates of psycho-
tropic medication use over time.
It is important to increase our knowledge regarding rates of
longitudinal medication use given the responsibility placed on child
welfare agencies and Medicaid to provide ongoing oversight and
coordination of mental health services, including medication, for
children removed from their homes under recently passed federal
legislation, ‘‘Fostering Connections to Success and Increasing
Adoptions Act’’ (P.L. 110–351) (United States 110th Congress
2008). Previous research using NSCAW indicates that outpatient
mental health service use varies over time, with a rapid increase in
outpatient use documented for all youths following investigation,
but particularly for youths placed in out-of-home care, even when
controlling for behavior problems (Leslie et al. 2005). If outpatient
services vary in relation to a CW=CPS investigation, it is possible
that rates of psychotropic medication use show a similar pattern and
increase substantively following investigation.
On the basis of these previous findings, we hypothesized that a
signification proportion of youths would show an increase in
medication use following investigation. Growth mixture modeling
(GMM) uses sophisticated statistical techniques to identify unob-
served subpopulations within a larger population group, taking into
account the nesting of time observations within individuals (Mu-
the´n and Muthe´n 2000; Muthe´n 2002). Thus, in this research, we
analyzed data from the NSCAW sample with the following aims:
(1) To identify distinct, heterogeneous groups of youths based on
individual longitudinal trajectories of psychotropic medication use,
and (2) to determine the impact of the child’s sociodemography,




The NSCAW study tracked a cohort of 5,501 U.S. children, aged
birth to 16 years at enumeration. The study was funded by the
Federal Administration on Children and Families, and data col-
lection was completed by the Research Triangle Institute (RTI).
RTI employed a two-stage, stratified-sample design. First, RTI
selected primary sampling units (PSUs) defined as geographic areas
that encompassed the population served by a single CW=CPS
agency and tended to represent single counties. Of the 100 selected
PSUs, seven were small and were combined with adjacent counties,
and eight had legislation in place limiting their participation. The
final sample comprised 92 PSUs, representing 97 counties. The
second-stage sampling identified 5,504 index children from lists of
children undergoing investigation from October, 1999, through
December, 2000, in PSUs. The framework oversampled for certain
subsets within CW=CPS, such as infants, sexually abused children,
and children receiving CW=CPS services. Approval for this study
was given by the U.S. Office of Management and Budget and the
Institutional Review Boards (IRB) of RTI, University of North
Carolina, Rady Children’s Hospital–San Diego, Tufts Medical
Center, and state or county IRBs representing communities in-
volved with the study. Face-to-face informed consent was obtained
by trained field representatives. For these analyses, we selected a
subsample of children ages 2 years and greater at wave 1.
Procedure
Interviews were conducted with youths (where age appropriate),
their caregivers, and their CW=CPS workers at wave 1 (baseline)
and at three follow-up intervals (12-month, 18-month, and 36-
month waves). Wave 1 interviews with child welfare workers were
completed on average 5.2 months after investigation (standard
deviation [SD]¼ 2.8 months) and with caregivers 5.6 months after
(SD¼ 2.8 months). Wave 2, 3, and 4 follow-up interviews with
caregivers were conducted on average at 13.9 (SD¼ 2.9), 21.0
(SD¼ 3.0), and 36.9 (SD¼ 2.9) months, respectively. At each
wave, respondents were asked whether the index child was cur-
rently using medications for emotional, behavioral, learning, at-
tentional, or substance abuse problems as well as using general
medical, outpatient specialty mental health services, and services in
restrictive settings (e.g., day treatment, residential care, inpatient
setting) for these types of problems. Attrition was limited; 71% of
cases were missing zero to one interviews across all child, care-
giver, and caseworker interviews.
Measures
Table 1 describes all variables and pertinent references. Child
demographics examined included youth age, gender, and
race=ethnicity. We also included maltreatment history at baseline
as a series of indicator variables, given the overlap in types of
maltreatment experienced by youths. Youths were considered in
need of mental health services if they scored in the clinical range
(64 or above) on the internalizing, externalizing, or total problem
subscales of the Parent Version of the Child Behavior Checklist
(CBCL) and=or the Youth Self-Report (YSR) for youths11 years
of age (Achenbach 1991; Achenbach 1992; Achenbach 1997). The
clinical cutoff point, rather than the borderline range, was used to
avoid inflating our estimate of need. The use of the CBCL as a
proxy for need for clinical services has been employed in multiple
mental health services research studies in the past (McIntyre and
Keesler 1986; Clausen et al. 1998; James et al. 2004). We included
insurance status as a control variable, given this may act to either
facilitate or hinder medication use. Finally, we included three
control variables (use of general medical services, use of outpatient
mental health services, and use of restrictive care [e.g., group home,
residential] services) to control for access to services and allow us
to better understand the impact of the primary variables in the
model. This approach has been previously used by other re-
searchers examining mental health service use (Zima et al. 1999a;
Raghavan et al. 2006; Horwitz et al., in press ). Our primary out-
comemeasure was groups of children derived using GMMbased on
medication use patterns over the four study waves (Wang and
Bodner 2007).
Data analysis
We employed GMM to identify distinct, heterogeneous groups
of children with varied medication use trajectories over time using
M-Plus, (Muthe´n and Muthe´n 2007), a statistical software package
well equipped to handle the complex issues that arise when ana-
lyzing growth curves. Missing data patterns were evaluated and
treated with full information maximum likelihood estimation for
missing values, capitalizing on all available data. After deriving the
groups, we employed chi-squared analyses and multivariate lo-
gistic regression, using SUDAAN version 10 (Research Triangle
Institute 2008), to estimate the associations between independent
variables and group membership. Both logistic and polychotomous
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regressions were run and demonstrated similar results; for this re-
search, we chose to display the regression models using separate
logistic regressions for ease of interpretation by the reader. Because
medication use group demonstrated a nonlinear relationship with
age, we chose to transform age into a categorical variable, with
three groupings: Children ages 2–5, ages 6–11, and ages 12 and
older. Because the models were tolerant of the inclusion of the three
service use variables included as control variables, these variables
were maintained in the model. Note that numbers and percentages
reported in all tables do not total 100% because the reported per-
centages are weighted to account for the sampling design.
Results
Sample characteristics
Characteristics of the sample are shown in Table 2. Approxi-
mately 10% of youths were in out-of-home care at wave 1; the other
90% were living with a parent or informally with kin. About half





Medication use Categorical variable measured at each wave
regarding medication use for
emotional=behavioral=learning=attentional
or substance use problems.
NA 1, 2, 3, 4 Caregiver
Medication use
group
Variable derived regarding medication use
patterns (low use, high use; increasing use).
NA NA Derived for this
study
Independent variables
Child placement Placement in out-of-home care at wave 1 (i.e.,
kinship care, non-relative foster care, group
home, residential care, other unspecified)
versus in-home
NA 1 Case records
Demographics Child’s age, gender, race=ethnicity NA 1 Case records
Maltreatment
history
Indicator variables for the presence or absence
of four different types of abuse: (1) Physical
abuse, (2) sexual abuse, (3) physical or







Dichotomous variable indicative of a
Externalizing, Internalizing, or Total
Problem score on the CBCL or the YSR at
or above the clinical cut point of T¼ 64;
available for ages 2þ in NSCAW. Two
forms of the CBCL were used: One for
children aged 2–3 years and another for









Categorical variable: (1) Medicaid,
(2) private=Champus, (3) uninsured.
NA 1 Caregiver report
General medical use Any general medical service for an emotional,
behavioral, learning, attentional, or
substance use problem. Referent time
period was over the 3 years of the study for




(Ascher et al. 1996)
1, 2, 3, 4 Caregiver report
Outpatient mental
health service use
Any outpatient mental health subspecialist
service (i.e., mental health center,
psychologist, psychiatrist, social worker, or
psychiatric nurse) for an emotional,
behavioral, learning, attentional, or
substance use problem. Referent time
period was over the 3 years of the study for




(Ascher et al. 1996)
1, 2, 3, 4 Caregiver report
Restrictive care use Any service in a restrictive setting (i.e.,
therapeutic nursery, day treatment, group
home, residential care, inpatient). Referent
time period was over the 3 years of the




(Ascher et al. 1996)
1, 2, 3, 4 Caregiver report
Abbreviations: NSCAW¼National Survey of Child and Adolescent Well-Being; NA¼ not applicable; CBCL¼Child Behavior Checklist;
YSR¼Youth Self-Report.
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(48%) of the sample were aged 6–11 years, with one third 2–5 years
of age (31%) and the rest 12 years or greater (21%). The proportion
of males and females was equivalent. Almost half (47%) of the
sample was Caucasian. Over half (55%) reported a history of ne-
glect, and more than one third (35%) reported physical abuse.
About 44% of youths had Total, Internalizing, or Externalizing
scores on the CBCL or YSR64. About two thirds (63%) endorsed
having Medicaid insurance coverage. About one quarter (27%)
reported seeing a general medical provider physician, 42% had
seen an outpatient mental health specialist, and 14% had spent time
in restrictive care.
At wave 1, 13% of children had used a medication for emo-
tional, behavioral, learning, attentional, or substance abuse prob-
lems; this increased to 16% by wave 4. Overall, 22% reported
using medication at one or more of the four study waves (data not
shown).
Table 2. Characteristics of Youths Aged 2 or More in the NSCAW Study by Medication-Use
Groupa,b: Age 2 (n¼ 2,521)
Independent variables
Increasing







n % (se) n % (se) n % (se) n (%)
Child’s placement at wave 1**
In home 82 77.7 (7.1) 197 82.6 (3.3) 1615 91.3 (1.0) 1894 89.7
Out of home 66 22.3 (7.1) 119 17.4 (3.3) 442 8.7 (1.0) 627 10.3
Child’s age***
2–5 36 19.8 (7.4) 17 8.9 (2.9) 721 34.6 (2.0) 774 31.0
6–11 82 62.2 (7.5) 184 57.0 (6.2) 902 46.5 (2.3) 1168 48.4
12þ 30 18.0 (4.9) 115 34.1 (5.4) 434 18.9 (1.6) 579 20.6
Child’s gender***
Male 97 75.1 (7.0) 198 67.2 (4.4) 880 43.2 (2.2) 1175 47.3
Female 51 24.9 (7.0) 118 32.8 (4.4) 1177 56.8 (2.2) 1346 52.7
Child’s race=ethnicity***
African American 39 16.5 (5.0) 70 14.3 (3.4) 636 31.0 (3.0) 745 28.5
Caucasian 72 66.6 (7.0) 196 67.0 (5.8) 916 43.3 (4.1) 1184 47.0
Hispanic 28 11.0 (3.8) 35 16.2 (5.2) 356 19.2 (3.7) 419 18.6
Other 9 5.9 (2.7) 15 2.6 (1.1) 146 6.5 (1.0) 170 6.0
Maltreatment history
Physical abuse*
Yes 53 51.9 (8.1) 117 48.0 (4.9) 593 32.7 (2.0) 763 35.2
No 89 48.1 (8.1) 173 52.0 (4.9) 1338 67.3 (2.0) 1600 64.8
Sexual abuse
Yes 25 8.5 (3.0) 56 13.2 (3.2) 356 13.7 (2.0) 437 13.5
No 117 91.5 (3.0) 234 86.8 (3.2) 1575 86.3 (2.0) 1926 86.5
Neglect*
Yes 90 58.6 (8.4) 144 39.5 (5.2) 1141 56.9 (2.4) 1375 55.0
No 52 41.4 (8.4) 146 60.5 (5.2) 790 43.1 (2.4) 988 45.0
Abandonment
Yes 10 3.2 (1.2) 14 4.2 (2.3) 80 2.2 (0.7) 104 2.4
No 132 96.8 (1.2) 276 95.8 (2.3) 1851 97.8 (0.7) 2259 97.6
CBCL=YSR total=externalizing=internalizing score at wave 1***
<64 44 26.7 (7.2) 57 19.4 (4.8) 1241 62.4 (2.1) 1342 56.0 (2.2)
64 104 73.3 (7.2) 259 80.6 (4.8) 814 37.6 (2.1) 1177 44.0 (2.0)
Child’s insurance status at wave 1*
Medicaid 116 72.2 (7.8) 255 70.0 (5.6) 1369 61.5 (2.5) 1740 62.9
Private=Champus 20 22.2 (7.9) 51 25.7 (5.0) 471 27.1 (2.0) 542 26.7
No insurance 12 5.6 (2.6) 10 4.3 (2.2) 207 11.4 (1.5) 229 10.4
Any restrictive care***
Yes 80 54.3 (8.0) 188 48.5 (5.3) 216 7.7 (0.8) 484 14.2
No 68 (45.7) (8.0) 128 51.5 (5.3) 1841 92.3 (0.8) 2037 85.8
Any outpatient specialty mental health service***
Yes 135 89.9 (4.1) 294 91.3 (2.9) 841 33.1 (2.7) 1270 42.1
No 13 10.1 (4.1) 22 8.7 (2.9) 1216 66.9 (2.7) 1251 57.9
Any general medical services***
Yes 111 84.1 (4.1) 257 82.5 (4.1) 357 17.0 (1.5) 725 27.2
No 37 15.9 (4.7) 59 17.5 (4.1) 1700 83.0 (1.5) 1796 72.8
National estimates (n, mean [se]) 52519 3.9 (0.6) 156747 11.6 (1.2) 1142905 84.5 (0.3) 1352170
aSee Table 1 for complete description of each variable.
bNote all percents are weighted to account for the study sampling plan.
*Significant at p< 0.05. **Significant at p< 0.01. ***Significant at p< 0.001.
Abbreviations: NSCAW¼National Survey of Child and Adolescent Well-Being; se¼ standard error; CBCL¼Child Behavior Checklist; YSR¼Youth
Self-Report.
138 LESLIE ET AL.
Three groups derived by latent class analysis
As is recommended, we tested multiple solutions including two-,
three-, and four-groupmodels. Indicators of good model fit in GMM
include a lower relative sample size-adjusted Bayesian information
criterion (SBIC) and a higher relative Entropy (values greater than
0.90), a summary number reflecting the quality of classification of
individuals into groups based on their posterior probabilities of
group membership for each group. We also considered utility of the
classification solution in practice (e.g., lack of overlap among
groups, large enough proportion of individuals within groups).
The three-group solution demonstrated the best fit based on the
criteria noted above (SBIC¼ 7345.883; Entropy¼ 0. 97), and the
groupswere identified as: (1) Low users, thosewho reported limited or
no medication use over time; (2) increasing users, those who initiate
medication use over time following an investigation; and (3) high
users, those who enter the system using medications or start within a
close time frame to the initial CW=CPS investigation and consistently
report use over time. The majority of youths (85%, n¼ 2057) were in
the low-use group, 4% (n¼ 148)were in the increasing-use group, and
12% (n¼ 316) were in the high-use group and endorsed medication
use across most and=or all of the 3 years of the study (see Fig. 1).
Characteristics of medication use groups
Table 2 demonstrates bivariate relationships between inde-
pendent variables and the three identified groups. Placement in
out-of-home care at wave 1 was more commonly seen in the in-
creasing-use group (w2¼ 5.13, degrees of freedom [df ]¼ 2,
n¼ 2,521, p¼0.0079). Males were more likely than females to be
in the high- or increasing-use groups (w2¼ 1,445, df¼ 2, n¼ 2,521,
p¼ 0.0000). Caucasians were more likely to be increasing- or high-
use group members; conversely, African Americans were more
likely to be in the low-use group (w2¼ 5.48, df¼ 6, n¼ 2,518,
p¼ 0.0001). The majority of 2 to 5 year olds were in the low-use
group. Preschoolers tended to be in the low and increasing-use
group, and youths 12 and up more likely to be in the high-use group
(w2¼ 13.50, df¼ 4, n¼ 2,521, p¼ 0.0000). Youths with a history
of physical abuse were more likely to be in the increasing- or high-
use groups (w2¼ 4.19, df¼ 2, n¼ 2,363, p¼ 0.0185). Youths with
a history of neglect were more likely to be in the increasing- or low-
use groups (w2¼ 3.93, df¼ 2, n¼ 2,363, p¼ 0.0234). Children
without insurance were more likely to be low users (w2¼ 2.60,
df¼ 4, n¼ 2,511, p¼ 0.042). Children with any general medical
(w2¼ 42.41, df¼ 2, n¼ 2,521, p¼ 0.0000), outpatient mental
health specialist use (w2¼ 40.36, df¼ 2, n¼ 2,521, p¼ 0.0000), or
restrictive care (w2¼ 17.24, df¼ 2, n¼ 2,521, p¼ 0.0000) were
more likely to be in the increasing- or high-use groups.
Predictors of group membership
Table 3 represents the logistic regression models delineating the
odds ratio for medication use by group for each independent vari-
able examined in the model, controlling for all other variables. The
referent group for both logistic regression models was the low-use
group.
In the multivariate logistic regression model comparing the
increasing- and low-use groups (see Table 3), several variables did
differentiate the two groups. Specifically, males were 4.16 times as
likely as females to be in the increasing-use group (95% confidence
interval [CI], 2.16, 8.00). Age was significant for the overall
comparison ( p¼ 0.02), but this was only apparent in the odds ratios
and confidence intervals when the age range 6–11 was used as the
reference group. Specifically, youths ages 12 and older were 0.35
times as likely to be in the increasing-use compared to youths ages
6–11 years (data not shown in table; 95% CI, 0.16, 0.76); no re-
lationship was noted in comparison to the preschool age group.
Youths with a history of physical abuse were 2.82 times as likely as
youths without a history of physical abuse to be in the increasing-
use group (95% CI, 1.37, 5.79). Use of general medical services












Wave 2Wave 1 Wave 3 Wave 4






Increasing medication use (n=148, 4%) 
High medication use (n=316, 12%)
Low medication use (n=2057, 85%)
FIG. 1. Weighted proportion of youths using medication in latent medication groups at each study wave (n¼ 2,521).
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mental health services (OR, 4.16; 95% CI, 1.44, 12.04), and re-
stricted care (OR, 6.12; 95% CI, 2.71, 13.82) were also strongly
associated with psychotropic medication use.
In the multivariate logistic regression model comparing the
high- and low-use groups (see Table 4), males were more likely to
be in the high-use group compared to females (OR, 2.86; 95% CI,
1.54, 5.30). Age also was associated with group membership;
youths ages 6–11 years and ages 12þ years were more likely to be
in the high-use group compared to youths ages 2–5 years (OR, 4.22;
95% CI, 1.72, 10.32; and OR, 3.10; 95% CI, 1.17, 8.19, respec-
tively). Unlike the previous model, race=ethnicity was associated
with group membership; African-American youths were 0.30 times
as likely to be in the high-use group compared to Caucasians (95%
CI, 0.14, 0.64). Behavioral status, as measured by a Total, Inter-
nalizing, or Externalizing Score 64 on the CBCL and=or YSR,
was also associated with being in the high-use group (OR, 2.70,
1.27, 5.75). Use of general medical services (OR, 8.33; 95% CI,
4.33, 16.04), outpatient specialty mental health services (OR, 7.20;
95% CI, 2.34, 22.14), and restricted care (OR, 3.54; 95% CI, 1.84,
6.82) were also positively associated with membership in the high-
use group compared to the low-use group.
Last, we compared the increasing-use group to the high-use
group (see Table 5). On multivariate logistic regression modeling,
only three variables were significant. Youths with a history of
physical abuse were more likely to be in the increasing-use group
compared to the high-use group (OR, 2.86; 95%CI, 1.15, 7.10), and
those with a history of neglect were similarly more likely to be in
the increasing-use group (OR, 4.48; 95% CI, 1.70, 11.78). Youths
who had used any restrictive care were also more likely to be
represented in the increasing-use group (OR, 2.62; 94% CI, 1.22,
5.61). Although age as an overall variable was marginally associ-
ated with group membership ( p¼ 0.08), youths ages 12 years and
older were less likely than youths ages 2–5 years (OR, 0.16; 95%
CI, 0.03, 0.81) to be in the increasing-use group.
Discussion
In this paper, we describe for the first time longitudinal patterns
of rates of psychotropic medication use among a nationally rep-
resentative sample of youths involved with CW=CPS. Reported
rates of medication use were 22% across the 3-year period, sug-
gesting that one fifth of all youths aged 2–16 years undergoing an
investigation report are likely to be taking psychotropic medica-
tions at some time within 3 years of an investigation. We found
three distinct medication use groups: (1) Low users, those who
reported limited or no medication use over time; (2) increasing
users, those who initiate medication use over time following an
investigation; and (3) high users, those who enter the system using
medications or start within a close time frame to the initial
CW=CPS investigation and consistently report use over time. The
majority of youths were in the low-use group; contrary to our
hypotheses, only a small proportion of youths (4%) were in the
increasing-use group. This suggests that only a limited proportion
of children begin medications following investigation. When
weighted back to the entire U.S. population of children undergoing
an investigation over a 15-month period from October, 1999, to
December, 2000, 1,142,905 children would most likely be classi-
fied as low users, 156,747 children as high users, and 52,519
children as increasing users over the 3-year follow-up period (see
Table 2).
Table 3. Logistic Regression Analysis: Increasing Medication-Use Group Compared to Low-Use Group (n¼ 2,060)
Independent variables Increasing medication use OR (95% CI)
Child’s placement in out-of-home care at wave 1 (in-home¼ reference) 1.56 (0.75, 3.27)
Child’s age (years)*
2–5 1.00
6–11 2.10 (0.89, 4.95)
12þ 0.72 (0.26, 2.01)
Child’s gender-male (female¼ reference)*** 4.16 (2.16, 8.00)
Child’s race=ethnicity
African American 0.54 (0.23, 1.28)
Hispanic 0.46 (0.17, 1.25)
Other 0.75 (0.14, 4.21)
Maltreatment history (no¼ reference for each type of maltreatment)
Physical abuse** 2.82 (1.37, 5.79)
Sexual abuse 1.18 (0.42, 3.28)
Neglect 1.61 (0.77, 3.38)
Abandonment 0.60 (0.18, 2.03)
CBCL=YSR total=externalizing=internalizing score at wave 1 64 (<64¼ reference) 2.01 (0.92, 4.38)
Child’s insurance
Medicaid 0.92 (0.20, 4.22)
Private=Champus 0.78 (0.17, 3.67)
No insurance 1.00
Any general medical services (no¼ reference)*** 6.93 (2.81, 17.06)
Any outpatient specialty mental health (no¼ reference)*** 4.16 (1.44, 12.04)
Any restrictive care (no¼ reference)*** 6.12 (2.71, 13.82)
*Significant at p< 0.05.
**Significant at p< 0.01.
***Significant at p< 0.001.
Abbreviations: OR¼Odds ratio; CI¼ confidence interval; CBCL¼Child Behavior Checklist; YSR¼Youth Self-Report.
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Our results indicate that there is considerable heterogeneity in
medication use trajectories following entry into child welfare,
even among youths demonstrating behavioral symptoms as mea-
sured on the CBCL=YSR. Only a limited number of youths start
medication after entry; a larger proportion of youths enter
CW=CPS with a history of medication use and generally maintain
that use over time. However, the majority of youths report limited
to no use of medication. Whether these rates of use reflect under
use, appropriate use, or over use of medications cannot be deter-
mined using the NSCAW data. It is striking, though, that only one
quarter (27%) reported seeing a general medical provider phy-
sician and less than half had seen an outpatient mental health
specialist (42%). This suggests that youths undergoing investiga-
tion are not well connected to health and mental health service
systems despite the fact that 44% had rates of need in the clinical
range on the CBCL, a high cut point indicating serious emotional
needs.
We next examined variables associated with group membership
in a multivariate model. Male gender was positively associated
with the increasing- and high-use groups in comparison to the low-
use group, but not in the comparison between the increasing-use
and high-use groups. Age displayed a complex relationship with
group membership. Youths ages 6–11 years and 12 years and
greater were more likely to be in the high-use group compared to
youths ages 2–5 years (reference group, low use). Youths ages 12
years and greater were less likely to be in the increasing-use group
compared to youths ages 6–11 years (reference group, low use) and
to preschool-age youths (reference group, high use). The use of
psychotropic medication among preschool and latency age children
in the increasing-use group is particularly worrisome, given
growing concerns regarding the trend in off-label use of psycho-
tropic medications among young children in the general population
(Vitiello 2001). Abuse similarly showed a complex relationship
with group membership. For youths in the increasing-use group, a
history of physical abuse but not behavioral problems was associ-
ated with group membership, when compared to low users. Con-
versely, behavioral status but not physical abuse was found to be
associated with high users compared to low users. Abuse type
(physical and neglect) differentiated between the increasing-
use and high-use groups. In addition, African-American youths
were less likely to be in the high-use group compared to the low-use
group. Placement, as defined as out-of-home versus in-home at
wave 1, was not associated with medication use group but time
spent in restrictive care was associated with both the increasing-use
and high-use groups.
Many of these variables have previously been linked tomedication
use, specifically older age (Zima et al. 1999b; dosReis et al. 2005;
Raghavan et al. 2005; Ferguson et al. 2006), male gender (dosReis
et al. 2005; Raghavan et al. 2005; Ferguson et al. 2006), Caucasian
race=ethnicity (Zima et al. 1999b; McMillen et al. 2004; Raghavan
et al. 2005; Ferguson et al. 2006), a history of physical abuse (Ra-
ghavan et al. 2005), public insurance (Raghavan et al. 2005), foster
care placement (dosReis et al. 2005), and placement in group homes
(Zima et al. 1999b; Breland-Noble et al. 2004). African-American
and Latino ethnicities, as well as history of neglect, have been asso-
ciated with decreased medication use in previous analyses of the
NSCAW data examining use at wave 2 (Raghavan et al. 2005). The
variation in the factors influencing medication use among the three
groups, even when controlling for behavioral status, reiterates find-
ings from previous studies—that medication use among children in
CW=CPS is not solely driven by clinical symptomatology, at least as
measured by the CBCL and YSR.
Table 4. Logistic Regression Analysis: High-Medication-Use Group Compared to Low-Use Group (n¼ 2,208)
Independent variables High medication use OR (95 % CI)
Child’s placement in out-of-home care at wave 1 (in-home¼ reference) 1.42 (0.68,2.58)
Child’s age (years)**
2–5 1.00
6–11** 4.22 (1.72, 10.32)
12þ* 3.10 (1.17, 8.19)
Child’s gender-male (female¼ reference)** 2.86 (1.54, 5.30)
Child’s race=ethnicity (Caucasian¼ reference)*
African American** 0.30 (0.14, 0.64)
Hispanic 0.99 (0.30, 3.27)
Other 0.46 (0.14, 1.50)
Maltreatment history (no¼ reference for each type of maltreatment)
Physical abuse 1.32 (0.68, 2.57)
Sexual abuse 0.77 (031, 1.89)
Neglect 0.67 (0.34, 1.33)
Abandonment 3.33 (0.34, 32.80)
CBCL=YSR total=externalizing=internalizing score at wave 1 64 (<64¼ reference)* 2.70 (1.27, 5.75)
Child’s insurance (no¼ reference)
Medicaid 2.59 (0.78, 8.57)
Private=Champus 2.89 (0.80, 10.36)
Any general medical services (no¼ reference)*** 8.33 (4.33, 16.04)
Any outpatient specialty mental health (no¼ reference)*** 7.20 (2.34, 22.14)
Any restrictive care (no¼ reference)*** 3.54 (1.84, 6.82)
*Significant at p< 0.05.
**Significant at p< 0.01.
***Significant at p< 0.001.
Abbreviations: OR¼Odds ratio; CI¼ confidence interval; CBCL¼Child Behavior Checklist; YSR¼Youth Self-Report.
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However, the novel findings in this research suggest that youths
vary in their trajectories of use and that these trajectories appear to
be associated with different independent variables. This research
suggests a number of future research questions to further disen-
tangle medication use patterns among youths in child welfare, in-
cluding: (1) The interplay between age, race=ethnicity, abuse
history, and behavioral status in predicting medication use, and (2)
medication use and its temporal relation to episode(s) of restricted
care. Last, these different patterns of medication use suggest social
workers, medical, and mental health clinicians are using some
mechanisms for classifying the mental health needs of youths as
they enter the child welfare system. How these decisions are made
and what modalities (i.e., psychotherapeutic as well as pharmaco-
logical) are recommended and then used deserves further explo-
ration.
Limitations
Some limitations of this study should be noted. Specifically,
NSCAW does not contain data to examine numbers or types of
medication used or patterns of episodic versus continuous use be-
tween waves. In addition, NSCAW did not garner clinical diag-
noses, either through a diagnostic interview or clinician-generated
administrative data, and thus we cannot comment on the quality of
care received. The proportion of children in out-of-home care
compared to in-home limited our ability to examine medication use
among children in different types of out-of-home care at wave 1.
Also, the different referent time periods for general medical and
subspecialty services for temporary and nonpermanent caregivers
makes comparisons across groups for these services incomplete.
Last, whether these rates of use reflect overutilization of psycho-
tropic medications cannot be determined using this large data
survey set and will require more complete measures of clinical need
as well as controlling for receipt and intensity of psychotherapeutic
modalities.
Conclusions
This study is the first to examine trajectories of medication use
longitudinally in a nationally representative probability sample of
youths in CW=CPS, thus avoiding sampling biases inherent in
cross-sectional and regional studies. The findings suggest that the
majority of youths undergoing an investigation have limited to no
use of psychotropic medication over time. However, there is a
unique subpopulation of youths who are consistently on medication
as well as a smaller group of youths who begin medication
following investigation. Understanding how clinical need, race=
ethnicity, gender, age, maltreatment history, and service use drive
variations in medication use over time will be critical for devel-
oping interventions to counter both under- and overprescribing of
medications to youths in CW=CPS and to assure quality mental
health care for these vulnerable youths.
Disclosures
Drs. Leslie, Raghavan, and Aarons and Mr. Zhang have no
conflicts of interest or financial ties to report.
Acknowledgments
The authors thank Dr. Scott Roesch, Ph.D., for his statistical
consultation and John Landsverk, Ph.D., for his mentorship. We
also thank Milena Doerfer, B.A., and Maia Hurley, MPP, Ph.D.,
funded research assistants under the Hood Foundation grant, for
their assistance with manuscript preparation. The National Survey
Table 5. Logistic Regression Analysis: Increasing Medication Use Group Compared to High-Use Group (n¼ 432)
Independent variables Increasing medication use OR (95% CI)
Child’s placement in out-of-home care at wave 1 (in-home¼ reference) 0.89 (0.43, 1.86)
Child’s age (years)
2–5 1.00
6–11 0.24 (0.06, 1.03)
12þ* 0.16 (0.03, 0.81)
Child’s gender-male (female¼ reference) 1.69 (0.71, 4.00)
Child’s race=ethnicity
African American 1.67 (0.64, 4.36)
Hispanic 0.58 (0.16, 2.11)
Other 4.42 (0.87, 22.37)
Maltreatment history (no¼ reference for each type of maltreatment)
Physical abuse* 2.86 (1.15, 7.10)
Sexual abuse 1.70 (0.46, 6.19)
Neglect** 4.48 (1.70, 11.78)
Abandonment 0.45 (0.10, 2.05)
CBCL=YSR total=externalizing=internalizing score at wave 1 64 (<64¼ reference) 0.46 (0.18, 1.19)
Child’s insurance
Medicaid 0.32 (0.07, 1.56)
Private=Champus 0.25 (0.05, 1.31)
No insurance 1.00
Any general medical services (no¼ reference) 0.75 (0.25, 2.23)
Any outpatient specialty mental health (no¼ reference) 0.83 (0.24, 2.87)
Any restrictive care (no¼ reference)* 2.62 (1.22, 5.61)
*Significant at p< 0.05.
**Significant at p< 0.01.
Abbreviations: OR¼Odds ratio; CI¼ confidence interval; CBCL¼Child Behavior Checklist; YSR¼Youth Self-Report.
142 LESLIE ET AL.
of Child and Adolescent Well-Being (NSCAW) was developed
under contract to RTI from the ACYF=DHHS. The information and
opinions expressed herein reflect solely the position of the au-
thor(s). Nothing herein should be construed to indicate the support
or endorsement of its content by ACYF=DHHS.
References
Achenbach TM: Manual for the Child Behavior Checklist=4–18 and
1991 profile. Burlington (Vermont): University of Vermont, De-
partment of Psychiatry, 1991.
Achenbach TM: Manual for the Child Behavior Checklist=2–3 and
1992 profile. Burlington (Vermont): University of Vermont, De-
partment of Psychiatry, 1992.
Achenbach TM: Manual for the Young Adult Self-Report and Young
Adult Behavior Checklist. Burlington (Vermont): University of
Vermont, Department of Psychiatry, 1997.
Ascher BH, Farmer EMZ, Burns BJ, Angold A: The Child and
Adolescent Services Assessment (CASA): Description and psy-
chometrics. J Emotion Behav Dis 4:12–20, 1996.
Breland-Noble AM, Elbogen EB, Farmer EM, Dubs MS, Wagner HR,
Burns BJ: Use of psychotropic medications by youths in therapeutic
foster care and group homes. Psychiatr Serv 55:706–708, 2004.
Burns BJ, Phillips SD, Wagner HR, Barth RP, Kolko DJ, Campbell Y,
Landsverk J: Mental health need and access to mental health ser-
vices by youths involved with child welfare: A national survey.
J Am Acad Child Adolesc Psychiatry 43:1–12, 2004.
Clausen JM, Landsverk J, Ganger W, Chadwick D, Litrownik A:
Mental health problems of children in foster care. J Child Fam
Studies 7:283–296, 1998.
dosReis S, Zito JM, Safer DJ, Gardner JF, Puccia KB, Owens PL:
Multiple psychotropic medication use for youths: A two-state
comparison. J Child Adolesc Psychopharmacol 15:68–77, 2005.
Dowd K, Kinsey S, Wheless S, Thissen R, Richardson J, Suresh R,
Mierzwa F, Biemer P, Johnson I, Lytle T: National Survey of Child
and Adolescent Well-Being: Combined Waves 1–4, Data File
User’s Manual. Ithaca (New York): National Data Archive on Child
Abuse and Neglect, 2004.
Ferguson DG, Glesener DC, Raschick M: Psychotropic drug use with
European American and American Indian children in foster care.
J Child Adolesc Psychopharmacol 16:474–481, 2006.
Horwitz SM, Hurlburt MS, Zhang J. Patterns and predictors of mental
health services use by children in contact with the child welfare
system. In: National Survey of Child and Adolescent Well-Being.
Webb, MB, Dowd K, Harden BJ, Landsverk J, Testa MF (eds.).
New York, Oxford University Press, 2010, pp. 279–329.
James S, Landsverk J, Slymen DJ, Leslie LK: Predictors of outpatient
mental health service use—the role of foster care placement
change. Ment Health Serv Res 6:127–141, 2004.
Landsverk JA, Garland AF, Leslie LK: Mental health services for
children reported to Child Protective Services. In: APSAC Hand-
book on Child Maltreatment. Myers JEB, Berliner L, Briere J,
Hendrix CT, Jenny C, Reid TA (eds.). Thousand Oaks (California),
Sage Publications, 2002, pp 487–507.
Leslie LK, Hurlburt MS, James S, Landsverk J, Slymen DJ, Zhang J:
Relationship between entry into child welfare and mental health
service use. Psychiatr Serv 56:981–987, 2005.
McIntyre A, Keesler TY: Psychological disorders among foster chil-
dren. J Clin Child Psychol 15:297–303, 1986.
McMillen JC, Scott LD, Zima BT, Ollie MT, Munson MR, Spitznagel
E: Use of mental health services among older youths in foster care.
Psychiatr Serv 55:811–817, 2004.
Muthe´n BO: Beyond SEM: General latent variable modeling. Beha-
viormetrika 29:81–117, 2002.
Muthe´n B, Muthe´n LK. Integrating person-centered and variable-
centered analyses: Growth mixture modeling with latent trajectory
classes. Alcohol Clin Exp Res 24:882–891, 2000.
Muthe´n LK, Muthe´n BO: Mplus user’s guide. Los Angeles (Cali-
fornia): Muthe´n & Muthe´n, 2007.
Olfson M, Marcus SC, Weissman MM, Jensen PS: National trends in
the use of psychotropic medications by children. J Am Acad Child
Adolesc Psychiatry 41:514–521, 2002.
Pilowsky D: Psychopathology among children placed in family foster
care. Psychiatr Serv 46:906–910, 1995.
Raghavan R, Zima BT, Andersen RM, Leibowitz AA, Schuster MA,
Landsverk J: Psychotropic medication use in a national probability
sample of children in the child welfare system. J Child Adolesc
Psychopharmacol 15:97–106, 2005.
Raghavan R, Leibowitz AA, Andersen RM, Zima BT, Schuster MA,
Landsverk J: Effects of Medicaid managed care policies on mental
health service use among a national probability sample of children
in the child welfare system. Child Youth Serv Rev 28:1482–1496,
2006.
Research Triangle Institute: SUDAAN Example Manual, Release
10.0. Research Triangle Park (North Carolina): Research Triangle
Institute, 2008.
Simms MD, Halfon N: The health care needs of children in foster
care: A research agenda. Child Welfare 73:505–524, 1994.
United States 110th Congress: Fostering Connections to Success and
Increasing Adoptions Act of 2008 (H.R.6893=P.L. 110-351), 2008.
U.S. Department of Health and Human Services, Administration for
Children, Youth and Families, Children’s Bureau: The AFCARSReport
2006: Preliminary estimates as of January, 2008a. Available at www.
acf.hhs.gov=programs=cb=stats_research=afcars=tar=report13.htm=.
U.S. Department of Health and Human Services, Administration on
Children, Youth and Families: Child Maltreatment 2006. Wa-
shington (DC): U.S. Government Printing Office, 2008b.
Vitiello B: Psychopharmacology for young children: Clinical needs
and research opportunities. Pediatrics 108:983–989, 2001.
Wang M, Bodner TE: Growth mixture modeling: Identifying and
predicting unobserved subpopulations with longitudinal data. Or-
ganiz Res Methods 10:635–656, 2007.
Zima BT, Bussing R, Crecelius GM, Kaufman A, Belin TR: Psy-
chotropic medication use among children in foster care: Relation-
ship to severe psychiatric disorders. Am J Public Health 89:
1732p1735, 1999a.
Zima BT, Bussing R, Crecelius GM, Kaufman A, Belin TR: Psy-
chotropic medication treatment patterns among school-aged chil-
dren in foster care. J Child Adolesc Psychopharmacol 9:135–147,
1999b.
Zito JM, Safer DJ, Sai D, Gardner JF, Thomas D, Coombes P, Du-
bowski M, Mendez-Lewis M: Psychotropic medication patterns
among youth in foster care. Pediatrics 121:e157–e163, 2008.
Address correspondence to:
Laurel K. Leslie, M.D., M.P.H.
Center on Child and Family Outcomes
Institute for Clinical Research and Health Policy Studies
Tufts Medical Center
800 Washington Street, Tufts MC #345
Boston, MA 02111
E-mail: lleslie@tuftsmedicalcenter.org
MEDICATION USE OVER TIME IN CHILD WELFARE 143

